Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer
The Long Run with Luke Timmerman
00:00
Intro
This chapter explores Bacara Therapeutics' pioneering efforts with Fiserafusp Alpha, a bifunctional antibody designed for head and neck cancer treatment. It discusses recent clinical trial results, market reactions, and the company's funding trajectory for future research.
Play episode from 00:00
Transcript
